Future of glaucoma treatment and management
Various new enhancements on the investigation front prescribe the battle against glaucoma is turning. New drugs are by and by entering the inside, close by better ways to deal with pass on them. There is creating assertion that the possible destiny of glaucoma organization will be build more in light of the optic nerve pathway from the retina to the visual cortex, and not by any means compelled to upgrading overflowing. Euro Times researches what glaucoma treatment may look like in the not so distant future. Glaucoma sickness can be controlled even with practical treatment; patients must have general eye examinations. Treatment as often as possible continues for the patient's lifetime. But troublesome, enduring treatment is attractive over vision adversity. Cutting down the intraocular weight is the focal point of treating patients with glaucoma. Conveying IOP is done down to a level that is not inclined to bring on extra optic nerve hurt; this level is suggested as the target weight and is controlled by the ophthalmologist. High IOP may hurt the optic nerve, which can provoke vision incident. The level differs for each patient, and a patient's target weight may change over the traverse of a lifetime. For open-edge he ophthalmologist may prescribe pharmaceutical to lower IOP. Topical or oral pharmaceuticals, implants or eye ointments can be used.